Silicon Laboratories Inc header image

Silicon Laboratories Inc

SLAB

Equity

ISIN null / Valor 1058474

NASDAQ (2025-11-21)
USD 120.92+4.17%

Silicon Laboratories Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Silicon Laboratories Inc is a semiconductor company that focuses on wireless connectivity for the Internet of Things, offering integrated hardware and software platforms, development tools, and ecosystem support for industrial, commercial, and home applications. The company is known for its high-performance, low-power, and secure multi-protocol solutions, as well as its commitment to sustainability through ESG principles. With a focus on employee wellbeing, product innovation, eco-efficient operations, climate change mitigation, and responsible supply chain management, Silicon Labs aims to be a leader in the semiconductor industry.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (21.11.2025):

Silicon Laboratories Inc reported results for the second quarter of 2025 (Q2 2025): revenue of $193 million, up 33% year‑over‑year, with GAAP net loss of $21.8 million (GAAP diluted loss per share $(0.67)) and non‑GAAP diluted earnings per share of $0.11. The company showed improving operating performance versus the prior year, maintained strong gross margins, and provided guidance for Q3 2025 with higher targeted margins and a non‑GAAP EPS range.

Revenue and segment growth

Total revenue was $193 million (+33% YoY). Industrial & Commercial revenue was $110 million (+25% YoY) and Home & Life revenue was $83 million (+45% YoY), indicating broad strength across end markets.

Profitability and margins

GAAP gross margin was 56.1% and non‑GAAP gross margin was 56.3%. On a GAAP basis the company recorded an operating loss of about $23 million and a GAAP diluted loss per share of $(0.67). On a non‑GAAP basis (adjusting for stock comp, intangible amortization and certain items) Silicon Labs reported roughly $1 million of operating income and non‑GAAP diluted EPS of $0.11.

Quarterly outlook (Q3 2025)

The press release gives guidance for Q3 2025 margins and expenses but did not include the revenue range in the published text. Guidance includes GAAP and non‑GAAP gross margin of 57%–58%; GAAP operating expenses of ~$130M–$133M (non‑GAAP op. expenses ~$107M–$110M); GAAP diluted loss per share $(0.60) to $(0.20); non‑GAAP diluted EPS $0.20 to $0.40.

Balance sheet & cash flow

Cash and cash equivalents were $314.5 million at quarter end (an increase of about $32.9 million in the quarter). Short‑term investments were about $101.1 million and total assets were roughly $1.22 billion. Inventories were $80.9 million, down versus the prior period.

Business milestones

Product achievements included the upcoming general availability of the SiXG301 — the company’s first Series 3 device and reported as the world’s first to achieve PSA Level 4 iSE/SE certification — and introduction of the SiXG302 Series 3 device expected to sample next year. Silicon Labs also announced its Works With developer conference series returning in 2025.

Summarized from source with an LLMView Source

Key figures

16.9%1Y
-12.1%3Y
8.55%5Y

Performance

50.1%1Y
45.8%3Y
45.0%5Y

Volatility

Market cap

3968 M

Market cap (USD)

Daily traded volume (Shares)

359,882

Daily traded volume (Shares)

1 day high/low

126.98 / 123.64

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Vertex Inc
Vertex Inc Vertex Inc Valor: 55908112
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%USD 19.79
All for One Group SE
All for One Group SE All for One Group SE Valor: 192106
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.46%EUR 39.80
AIXTRON SE
AIXTRON SE AIXTRON SE Valor: 4566068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.21%EUR 16.32
Procore Technologies Inc
Procore Technologies Inc Procore Technologies Inc Valor: 53026320
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.30%USD 71.09
Entegris Inc
Entegris Inc Entegris Inc Valor: 1102899
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.06%USD 73.66
Exact Sciences Corp
Exact Sciences Corp Exact Sciences Corp Valor: 1183218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 100.90
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%CHF 303.00
Privia Health Group Inc
Privia Health Group Inc Privia Health Group Inc Valor: 111013233
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.28%USD 23.74
RxSight Inc
RxSight Inc RxSight Inc Valor: 112649019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.41%USD 10.15
stock3 AG
stock3 AG stock3 AG Valor: 117302445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%EUR 29.80